These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8335947)

  • 1. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis.
    Crofford LJ; Sano H; Karalis K; Friedman TC; Epps HR; Remmers EF; Mathern P; Chrousos GP; Wilder RL
    J Immunol; 1993 Aug; 151(3):1587-96. PubMed ID: 8335947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urocortin in the synovial tissue of patients with rheumatoid arthritis.
    Uzuki M; Sasano H; Muramatsu Y; Totsune K; Takahashi K; Oki Y; Iino K; Sawai T
    Clin Sci (Lond); 2001 Jun; 100(6):577-89. PubMed ID: 11352772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing hormone signaling in synovial tissue from patients with early inflammatory arthritis is mediated by the type 1 alpha corticotropin-releasing hormone receptor.
    McEvoy AN; Bresnihan B; FitzGerald O; Murphy EP
    Arthritis Rheum; 2001 Aug; 44(8):1761-7. PubMed ID: 11508426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis.
    Hashimoto A; Hayashi I; Murakami Y; Sato Y; Kitasato H; Matsushita R; Iizuka N; Urabe K; Itoman M; Hirohata S; Endo H
    J Rheumatol; 2007 Nov; 34(11):2144-53. PubMed ID: 17918787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the nuclear orphan receptor NURR1 in the regulation of corticotropin-releasing hormone expression and actions in human inflammatory arthritis.
    Murphy EP; McEvoy A; Conneely OM; Bresnihan B; FitzGerald O
    Arthritis Rheum; 2001 Apr; 44(4):782-93. PubMed ID: 11315917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis.
    Crofford LJ; Sano H; Karalis K; Webster EL; Goldmuntz EA; Chrousos GP; Wilder RL
    J Clin Invest; 1992 Dec; 90(6):2555-64. PubMed ID: 1281840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium.
    Firestein GS; Berger AE; Tracey DE; Chosay JG; Chapman DL; Paine MM; Yu C; Zvaifler NJ
    J Immunol; 1992 Aug; 149(3):1054-62. PubMed ID: 1386092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells.
    Kumon Y; Suehiro T; Hashimoto K; Nakatani K; Sipe JD
    J Rheumatol; 1999 Apr; 26(4):785-90. PubMed ID: 10229397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis.
    Yamamura M; Kawashima M; Taniai M; Yamauchi H; Tanimoto T; Kurimoto M; Morita Y; Ohmoto Y; Makino H
    Arthritis Rheum; 2001 Feb; 44(2):275-85. PubMed ID: 11229457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential changes of corticotropin releasing hormone (CRH) concentrations in plasma and synovial fluids of patients with rheumatoid arthritis (RA).
    Nishioka T; Kurokawa H; Takao T; Kumon Y; Nishiya K; Hashimoto K
    Endocr J; 1996 Apr; 43(2):241-7. PubMed ID: 9026271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
    Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
    Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High CCL18/PARC expression in articular cartilage and synovial tissue of patients with rheumatoid arthritis.
    Momohara S; Okamoto H; Iwamoto T; Mizumura T; Ikari K; Kawaguchi Y; Takeuchi M; Kamatani N; Tomatsu T
    J Rheumatol; 2007 Feb; 34(2):266-71. PubMed ID: 17304652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis.
    Blaschke S; Schulz H; Schwarz G; Blaschke V; Müller GA; Reuss-Borst M
    J Rheumatol; 2001 Jan; 28(1):12-21. PubMed ID: 11196512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin 3 and its binding protein in rheumatoid arthritis.
    Ohshima S; Kuchen S; Seemayer CA; Kyburz D; Hirt A; Klinzing S; Michel BA; Gay RE; Liu FT; Gay S; Neidhart M
    Arthritis Rheum; 2003 Oct; 48(10):2788-95. PubMed ID: 14558084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the precursor of secretoneurin, secretogranin II, in the synovium of patients with rheumatoid arthritis and osteoarthritis.
    Sprott H; Pap T; Rethage J; Wintersberger W; Gay RE; Bradley LA; Uebelhart D; Gay S
    J Rheumatol; 2000 Oct; 27(10):2347-50. PubMed ID: 11036828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synovial fluids from patients with osteoarthritis and rheumatoid arthritis contain high levels of parathyroid hormone-related peptide.
    Kohno H; Shigeno C; Kasai R; Akiyama H; Iida H; Tsuboyama T; Sato K; Konishi J; Nakamura T
    J Bone Miner Res; 1997 May; 12(5):847-54. PubMed ID: 9144352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of sulfidopeptide leukotrienes and their metabolism in human synovial fluid of patients with rheumatoid arthritis.
    Koshihara Y; Isono T; Oda H; Karube S; Hayashi Y
    Prostaglandins Leukot Essent Fatty Acids; 1988 Jun; 32(3):113-9. PubMed ID: 2842805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.
    Pierer M; Brentano F; Rethage J; Wagner U; Hantzschel H; Gay RE; Gay S; Kyburz D
    Rheumatology (Oxford); 2007 Jul; 46(7):1063-70. PubMed ID: 17426140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis.
    Menkes CJ; Renoux M; Laoussadi S; Mauborgne A; Bruxelle J; Cesselin F
    J Rheumatol; 1993 Apr; 20(4):714-7. PubMed ID: 7684449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis.
    Hashimoto H; Tanaka M; Suda T; Tomita T; Hayashida K; Takeuchi E; Kaneko M; Takano H; Nagata S; Ochi T
    Arthritis Rheum; 1998 Apr; 41(4):657-62. PubMed ID: 9550474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.